0

Anticoccidial Drugs Market by Type and Geography - Forecast and Analysis 2022-2026

  • Published: Jul 2022
  • Pages: 124
  • SKU: IRTNTR73955
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Safe and Secure SSL Encrypted

info
close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization)
    Complimentary Customization Included

2500 USD

The anticoccidial drugs market share is expected to increase to USD 76.95 million from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 4.1%.

This anticoccidial drugs market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers anticoccidial drug market segmentation by type (ionophore anticoccidial and chemical derivative anticoccidial) and geography (North America, Europe, Asia, and Rest of World (ROW)). The anticoccidial drugs market report also offers information on several market vendors, including Bayer AG, Bioproperties Pty Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Cronus Pharma, Elanco Animal Health Inc., Huvepharma EOOD, Impextraco NV, Kemin Industries Inc., LABORATORIOS HIPRA SA, Merck and Co. Inc., Novartis AG, Phibro Animal Health Corp., Qilu Animal Health Products Co., Ltd., Vetoquinol SA, VH Group, Virbac, and Zoetis Inc. among others.

What will the Anticoccidial Drugs Market Size be During the Forecast Period?

Anticoccidial Drugs Market Size

Download the Free Report Sample to Unlock the Anticoccidial Drugs Market Size for the Forecast Period and Other Important Statistics

 

Anticoccidial Drugs Market: Key Drivers, Trends, and Challenges

The growing demand for feed additives owing to rising disease outbreaks in livestock is notably driving the anticoccidial drugs market growth, although factors such as stringent government regulations may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the anticoccidial drugs industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Anticoccidial Drugs Market Driver

The growing demand for feed additives owing to rising disease outbreaks in livestock is one of the key drivers fueling the anticoccidial drugs market growth. Disease outbreaks affect animal health and lead to the loss of livestock. They also disrupt livestock product trade and inhibit sustained investments in livestock production. The use of feed additives, such as anticoccidial drugs, prevents coccidiosis in poultry and other animals and improves the overall feed absorption and assimilation. This apparent benefit and its increasing awareness and acceptance among livestock producers are expected to drive the global anticoccidial market during the forecast period.

Key Anticoccidial Drugs Market Trend

Advances in biotechnology is one of the key anticoccidial drugs market trends propelling the market growth. Primarily, genomic analysis of all seven Eimeria species that cause coccidiosis in poultry has been accomplished, which may lead to the identification and validation of species-specific protein targets. Moreover, new research on Eimeria species is helping vendors to launch new anticoccidial drugs. For instance, in March 2021, Elanco Animal Health Inc. launched two new veterinary products in Sri Lanka via the local agent Baur and Co. The two products are anticoccidial feed additives. Such new drug discoveries will propel market growth during the forecast period.

Key Anticoccidial Drugs Market Challenge

Stringent government regulations is one of the key factors limiting the anticoccidial drug market growth. There are some restrictions imposed on the use of veterinary drugs or feed additives, which compel manufacturers to follow regulations. For instance, In 2017, the US restricted the use of medically important antibiotics in feed to VFD that require veterinary oversight. The use of a VFD drug in feed is permitted only under the professional supervision of a licensed veterinarian. All agricultural and veterinary chemical products sold in Australia must be registered by the Australian Pesticides and Veterinary Medicines Authority (APVMA). Therefore, such imposed stringent regulations may limit the market growth during the forecast period.

This anticoccidial drugs market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global anticoccidial drugs market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the anticoccidial drugs market during the forecast period.

Who are the Major Anticoccidial Drugs Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Bayer AG
  • Bioproperties Pty Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Cronus Pharma
  • Elanco Animal Health Inc.
  • Huvepharma EOOD
  • Impextraco NV
  • Kemin Industries Inc.
  • LABORATORIOS HIPRA SA
  • Merck and Co. Inc.
  • Novartis AG
  • Phibro Animal Health Corp.
  • Qilu Animal Health Products Co., Ltd.
  • Vetoquinol SA
  • VH Group
  • Virbac
  • Zoetis Inc.

 

This statistical study of the anticoccidial drugs market encompasses successful business strategies deployed by the key vendors. The anticoccidial drugs market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

  • Bayer.com - The company offers Anticoccidial that includes Polyether antibiotics, Ionophores, Monovalent ionophores, and Monovalent glycosidic ionophores.
  • Boehringer-ingelheim.com - The company offers Anticoccidial that includes Hatchpak cocci, which are used to aid in the prevention of coccidiosis.
  • Ceva.com - The company offers Anticoccidial that includes IMMUCOX which is designed to help healthy Chicken Broilers and Roasters develop immunity to coccidiosis.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The anticoccidial drugs market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Anticoccidial Drugs Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the anticoccidial drugs market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Anticoccidial Drugs Market?

Anticoccidial Drugs Market Share by Geography

For more insights on the market share of various regions Request for a FREE sample now!

42% of the market’s growth will originate from North America during the forecast period. The US is the key market for the anticoccidial drugs market in North America. Market growth in this region will be slower than the growth of the market in Asia.

The increasing livestock in the region, rising demand for quality, and growing concerns about livestock health will facilitate the anticoccidial drugs market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The outbreak of COVID-19 had a negative impact on the regional market. However, the region has been gradually propelling its economic activities due to large-scale vaccination drives since 2021, which are further supporting the growth of the regional economy. This further boosts the growth of the regional livestock activities and, consequently, is expected to drive the growth of the regional market during the forecast period.

What are the Revenue-generating Type Segments in the Anticoccidial Drugs Market?

Anticoccidial Drugs Market Share

To gain further insights on the market contribution of various segments Request for a FREE sample

The anticoccidial drugs market share growth by the ionophore anticoccidial segment will be significant during the forecast period. Ionophores have been the most preferred drugs to control coccidiosis as it slowly develops resistance in animals, and they do not completely suppress parasite development, thus allowing the development of immunity in animals after the first exposure. The divalent ionophore lasalocid has been shown to de- crease oocyst production in naturally infected lambs and cattle and in a few cases improve performance and reduce clinical signs of disease when included in the fee Ionophores, also used for lamb and cattle. Such factors are expected to boost the market growth during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the anticoccidial drugs market size and actionable market insights on post COVID-19 impact on each segment.

 

Anticoccidial Drugs Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 4.1%

Market growth 2022-2026

$ 76.95 million

Market structure

Fragmented

YoY growth (%)

3.5

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 42%

Key consumer countries

US, Germany, UK, China, and Japan

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Bayer AG, Bioproperties Pty Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Cronus Pharma, Elanco Animal Health Inc., Huvepharma EOOD, Impextraco NV, Kemin Industries Inc., LABORATORIOS HIPRA SA, Merck and Co. Inc., Novartis AG, Phibro Animal Health Corp., Qilu Animal Health Products Co., Ltd., Vetoquinol SA, VH Group, Virbac, and Zoetis Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Anticoccidial Drugs Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive anticoccidial drugs market growth during the next five years
  • Precise estimation of the anticoccidial drugs market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the anticoccidial drugs industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of anticoccidial drugs market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Type

    • 5.1 Market segments
      • Exhibit 24: Chart on Type - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
    • 5.2 Comparison by Type
      • Exhibit 26: Chart on Comparison by Type
      • Exhibit 27: Data Table on Comparison by Type
    • 5.3 Ionophore anticoccidial - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Ionophore anticoccidial - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Ionophore anticoccidial - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Ionophore anticoccidial - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Ionophore anticoccidial - Year-over-year growth 2021-2026 (%)
    • 5.4 Chemical derivative anticoccidial - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Chemical derivative anticoccidial - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Chemical derivative anticoccidial - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Chemical derivative anticoccidial - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Chemical derivative anticoccidial - Year-over-year growth 2021-2026 (%)
    • 5.5 Market opportunity by Type
      • Exhibit 36: Market opportunity by Type ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 38: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 40: Chart on Geographic comparison
      • Exhibit 41: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Germany - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.9 UK - Market size and forecast 2021-2026
      • Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.10 China - Market size and forecast 2021-2026
      • Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.11 Japan - Market size and forecast 2021-2026
      • Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 78: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 81: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 82: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 83: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 84: Matrix on vendor position and classification
            • 10.3 Bayer AG
              • Exhibit 85: Bayer AG - Overview
              • Exhibit 86: Bayer AG - Business segments
              • Exhibit 87: Bayer AG - Key offerings
              • Exhibit 88: Bayer AG - Segment focus
            • 10.4 Boehringer Ingelheim International GmbH
              • Exhibit 89: Boehringer Ingelheim International GmbH - Overview
              • Exhibit 90: Boehringer Ingelheim International GmbH - Business segments
              • Exhibit 91: Boehringer Ingelheim International GmbH - Key news
              • Exhibit 92: Boehringer Ingelheim International GmbH - Key offerings
              • Exhibit 93: Boehringer Ingelheim International GmbH - Segment focus
            • 10.5 Ceva Sante Animale
              • Exhibit 94: Ceva Sante Animale - Overview
              • Exhibit 95: Ceva Sante Animale - Product / Service
              • Exhibit 96: Ceva Sante Animale - Key offerings
            • 10.6 Elanco Animal Health Inc.
              • Exhibit 97: Elanco Animal Health Inc. - Overview
              • Exhibit 98: Elanco Animal Health Inc. - Product / Service
              • Exhibit 99: Elanco Animal Health Inc. - Key offerings
            • 10.7 Impextraco NV
              • Exhibit 100: Impextraco NV - Overview
              • Exhibit 101: Impextraco NV - Product / Service
              • Exhibit 102: Impextraco NV - Key offerings
            • 10.8 LABORATORIOS HIPRA SA
              • Exhibit 103: LABORATORIOS HIPRA SA - Overview
              • Exhibit 104: LABORATORIOS HIPRA SA - Product / Service
              • Exhibit 105: LABORATORIOS HIPRA SA - Key offerings
            • 10.9 Merck and Co. Inc.
              • Exhibit 106: Merck and Co. Inc. - Overview
              • Exhibit 107: Merck and Co. Inc. - Business segments
              • Exhibit 108: Merck and Co. Inc. - Key news
              • Exhibit 109: Merck and Co. Inc. - Key offerings
              • Exhibit 110: Merck and Co. Inc. - Segment focus
            • 10.10 Novartis AG
              • Exhibit 111: Novartis AG - Overview
              • Exhibit 112: Novartis AG - Business segments
              • Exhibit 113: Novartis AG - Key offerings
              • Exhibit 114: Novartis AG - Segment focus
            • 10.11 Virbac
              • Exhibit 115: Virbac - Overview
              • Exhibit 116: Virbac - Business segments
              • Exhibit 117: Virbac - Key offerings
              • Exhibit 118: Virbac - Segment focus
            • 10.12 Zoetis Inc.
              • Exhibit 119: Zoetis Inc. - Overview
              • Exhibit 120: Zoetis Inc. - Business segments
              • Exhibit 121: Zoetis Inc. - Key news
              • Exhibit 122: Zoetis Inc. - Key offerings
              • Exhibit 123: Zoetis Inc. - Segment focus

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 124: Inclusions checklist
                • Exhibit 125: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 126: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 127: Research methodology
                • Exhibit 128: Validation techniques employed for market sizing
                • Exhibit 129: Information sources
              • 11.5 List of abbreviations
                • Exhibit 130: List of abbreviations
              • health: Includes veterinary drugs (excluded from the scope of the report)

                Research Framework

                Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                TechnavioINFORMATION SOURCES

                Primary sources

                • Manufacturers and suppliers
                • Channel partners
                • Industry experts
                • Strategic decision makers

                Secondary sources

                • Industry journals and periodicals
                • Government data
                • Financial reports of key industry players
                • Historical data
                • Press releases
                Technavio

                TechnavioDATA ANALYSIS

                Data Synthesis

                • Collation of data
                • Estimation of key figures
                • Analysis of derived insights

                Data Validation

                • Triangulation with data models
                • Reference against proprietary databases
                • Corroboration with industry experts
                Technavio

                TechnavioREPORT WRITING

                Qualitative

                • Market drivers
                • Market challenges
                • Market trends
                • Five forces analysis

                Quantitative

                • Market size and forecast
                • Market segmentation
                • Geographical insights
                • Competitive landscape
                Interested in this report?
                Get your sample now!
                Anticoccidial Drugs Market market growth will increase by $76.95 mn during 2022-2026.
                The anticoccidial drugs market market is expected to grow at a CAGR of 4.1% during 2022-2026.
                Technavio has segmented the anticoccidial drugs market market by type (Ionophore anticoccidial and Chemical derivative anticoccidial) and geography (North America, Europe, Asia, and Rest of World (ROW)).
                Bayer AG, Bioproperties Pty Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Cronus Pharma, Elanco Animal Health Inc., Huvepharma EOOD, Impextraco NV, Kemin Industries Inc., LABORATORIOS HIPRA SA, Merck and Co. Inc., Novartis AG, Phibro Animal Health Corp., Qilu Animal Health Products Co., Ltd., Vetoquinol SA, VH Group, Virbac, Zoetis Inc. are a few of the key vendors in the anticoccidial drugs market market.
                North America will register the highest growth rate of 42% among the other regions. Therefore, the anticoccidial drugs market market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
                The key factors driving the anticoccidial drugs market market growth are:
                • Growing demand for feed additives owing to rising disease outbreaks in livestock
                • Advances in biotechnology
                The anticoccidial drugs market market vendors should focus on grabbing business opportunities from the ionophore anticoccidial segment as it accounted for the largest market share in the base year.
                • What are the key global market and the regional market share?
                • What are the revenue-generating key market segments?
                • What are the key factors driving and challenging this market’s growth?
                • Who are the key market vendors and their growth strategies?
                • What are the latest trends influencing the growth of this market?
                • What are the variables influencing the market growth in the primary regions?
                • What are the factors influencing the growth of the parent market?
                • Off-the-shelf research reports
                • Reports can be tailored to meet the customer's needs
                • Trusted by more than 100 fortune 500 organizations
                • Information about the market's key drivers, trends, and challenges
                • Parent market analysis
                • Every week, 50,000 people visit our subscription platform
                • Detailed vendors report with competitive landscape
                • Covid-19 impact and recovery analysis
                • Data on revenue-generating market segments
                • Details on the market shares of various regions
                • Five-force market analysis

                Certified ISO 9001 : 2015

                We are ISO recognized

                We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

                We are GDPR and CCPA compliant

                We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

                Safe and Secure SSL Encrypted
                Technavio

                info
                close
                • Single:

                  One user only.
                  Quick & easy download option

                • Enterprise:

                  Unlimited user access (Within your organization)
                  Complimentary Customization Included

                2500 USD

                Technavio Get the report (PDF) sent to your email within minutes.

                Subscribe & Save

                Get lifetime access to our
                Technavio Insights

                Customized Report as per your Business Needs

                • Our analysts will work directly with you and understand your needs
                • Get data on specified regions or segments, competitor and Vendors
                • Data will be formatted and presented as per your requirements
                • We offer $1000 worth of FREE customization at the time of purchase

                Let us help you make report more suited to your requirements.

                • Get a competitive breakdown as per your niche industry
                • Customize the data with various metrics that meet your business prerequisite
                • Understand Revenue Sources, Customers and many more
                • Details on Market Share
                • These customizations are done in a short amount of time by our analysts and industry experts
                Technavio
                Enquire Before Buying
                17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>